Navigation Links
HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
Date:5/29/2008

-Technology for quantitative profiling of protein biomarkers in tissue now available to investigators at DF/HCC member institutions through Brigham

and Women's Pathology Core Facility-

NEW HAVEN, Conn., May 29 /PRNewswire/ -- HistoRx, Inc., announced today that the pathology core facility at Brigham and Women's Hospital (BWH) will begin making the company's AQUA(R) technology for protein biomarker profiling available to the more than 900 Dana-Farber/Harvard Cancer Center (DF/HCC) scientists that are serviced by the facility. Brigham and Women's purchased a HistoRx PM-2000(TM) tissue analysis platform instrument, which incorporates the proprietary AQUA(R) technology, in 2005.

The pathology core facility at BWH is a service hub that provides state-of-the-art tissue-based tests and analysis to investigators at DF/HCC institutions, which include Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Children's Hospital Boston, Beth Israel Deaconess Hospital, and Massachusetts General Hospital. The core facility is using the AQUA(R) technology to identify and quantify protein biomarkers in tissue samples for researchers advancing studies on cancer diagnostics and drug development. Jon Aster, M.D., Ph.D., core facility director and Associate Professor in the Department of Pathology, and Scott Rodig, M.D., Ph.D., Assistant Professor in Pathology, both of BWH, will oversee the technology access expansion to the DF/HCC member institutions.

The PM-2000(TM) system, now in use at 12 leading cancer and pathology research centers through the HARP(TM) program (HistoRx Academic Research Program), enables the reliable measurement of protein biomarkers in tissue and tissue microarrays based on fluorescent immunohistochemical methods. Assays developed on the system may be used to better understand the origins of diseases as well as to aid in patient selection for clinical tri
'/>"/>

SOURCE HistoRx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
2. Favrille Announces Workforce Reduction
3. AMT Announces Presentations During the 11th Annual Meeting of the ASGT
4. Genmab Announces 2008 First Quarter Results
5. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
6. National Stem Cell Holding, Inc. Announces the Change of Its Name to Proteonomix, Inc.
7. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
8. WuXi PharmaTech Announces First Quarter 2008 Results
9. WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10, 2008
10. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
11. CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Israel , July 25, 2014  Galmed Pharmaceuticals ... biopharmaceutical company focused on the development and commercialization of ... diseases and cholesterol gallstones, today announced financial results for ... Half 2014 Financial Summary: , Reported cash and ... compared with $137,000 at December 31, 2013.  , ...
(Date:7/24/2014)... New York, NY - July 24, 2014 -- Keryx ... results from the long-term, randomized, active control Phase 3 ... ferric iron-based phosphate binder, for the treatment of hyperphosphatemia ... The PERFECTED study (PhosphatE binding and iRon delivery with ... the Journal of the American Society of Nephrology ...
(Date:7/24/2014)... 24, 2014  Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), ... of regenerative medicine, announced today that it will ... investors on Tuesday, July 29, 2014, at 4:30 ... include an overview of Asterias, business strategy and ... http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes before ...
(Date:7/24/2014)... yet to materialise. Yet, scientists are making progress ... faster. One such approach relies on quantum dotsa ... an electric field. A new study demonstrates that ... dots (TQDs) with electrical impulses can help better ... TQDs be used as quantum information units, which ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... Germany and MINNEAPOLIS, Minnesota, February 11, Bayer HealthCare ... Minneapolis, MN, (Nasdaq: POSS ), announced today ... pursuant to which,MEDRAD will acquire Possis Medical in ... or a total equity value of approximately US-Dollar ...
... Feb. 11 Replikins Ltd. announced that the,quantitative ... structure,predicts that the current H5N1 cycle is over. ... and high mortality characteristics,are expected to subside - ... or,another influenza virus strain begins., 140,000 virus ...
... Cryo-Cell,International, Inc. (OTC Bulletin Board Symbol: CCEL) (the ... family cord blood banks, today,announced results for fiscal ... ended November 30, 2007 were,approximately $17.5 million, up ... ended November 30, 2006. The Company reported a ...
Cached Biology Technology:Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 2Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 3Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 4Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 5Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 6FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over 2Cryo-Cell International, Inc. Reports Results for Fiscal 2007 2Cryo-Cell International, Inc. Reports Results for Fiscal 2007 3Cryo-Cell International, Inc. Reports Results for Fiscal 2007 4Cryo-Cell International, Inc. Reports Results for Fiscal 2007 5Cryo-Cell International, Inc. Reports Results for Fiscal 2007 6
(Date:7/24/2014)... at Albert Einstein College of Medicine of ... J. Fox Foundation for Parkinson,s Research to translate a ... This drug discovery project will test chemical compounds on ... a drug that acts on an underlying cause of ... help many people manage their symptoms, we are eager ...
(Date:7/24/2014)... NJIT this week for an all-day public forum on ... Agency (EPA) to dredge toxic sediment from an eight-mile ... has called the plan, which proposes removing 4.3 million ... the riverbed, one of the largest cleanups in the ... disposed off-site. , "We need to ensure the future ...
(Date:7/24/2014)... researchers and patients have hoped that embryonic stem cells ... bodycould provide insight into numerous diseases perhaps even be ... by the inability to transfer research and tools from ... because human ESCs are "primed" and slightly less plastic ... Powell, and Haoyi Wang, who are scientists in the ...
Breaking Biology News(10 mins):Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2
... Imagine a polka-dotted postage stamp that can sniff out poisonous ... reported in the Sept. 13 issue of the journal ... University of Illinois have developed an artificial nose for the ... fast and inexpensive and works by visualizing odors. ...
... The master gene that causes blood stem cells to ... identified by scientists, in a study published in Nature ... boost the body,s production of these frontline tumour-killing cells, creating ... ,knocked out, the gene in question, known as E4bp4, in ...
... a widespread and expensive social problem. Recent research ... interaction between genetic inheritance and environment for development ... common knowledge that childhood maltreatment often causes psychiatric ... (e.g. aggression or antisocial behaviour) later in life. ...
Cached Biology News:Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Master gene that switches on disease-fighting cells identified by scientists 2Master gene that switches on disease-fighting cells identified by scientists 3Are the monoamines involved in shaping conduct disorders? 2Are the monoamines involved in shaping conduct disorders? 3Are the monoamines involved in shaping conduct disorders? 4Are the monoamines involved in shaping conduct disorders? 5Are the monoamines involved in shaping conduct disorders? 6
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... large numbers of samples may be carried out ... operator attention. System control and data processing ... 4900. The elegant, powerful and very easy ... Windows 98 and 2000., The supplied detector is ...
Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...
Biology Products: